Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in
Panacea Biotec Limited
-(PANACEABIO)
XNSE:PANACEABIO, XBOM:PANACEABIO
Panacea Biotec Q4FY23 Earnings Story
Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in
Panacea Biotec Q4FY23; 8% Fall in Revenues
Panacea Biotec Ltd.’s revenue in Q4FY23 rose 13% to ₹ 12,557 crores. Consolidated Profit After Tax came at ₹ 4,320 crores in
Panacea Biotec Limited: Making India Healthier
Panacea Biotec Limited is an Indian pharmaceutical company that is engaged in research, development, and manufacturing of pharmaceuticals, vaccines, and natural products.
Panacea Biotec Limited Q3FY23 Earnings Story
With very few suppliers in the vaccination market, this creates an opportunity for India’s leading vaccine developer – Panacea Biotec Limited. Panacea
Panacea Biotec Q3FY23; 26% Fall in Revenue
Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937 lakhs in
Panacea Biotech Q1FY23 Net profit soars by 2%
Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores
Decoding Panacea Biotec Limited: India’s leading Vaccine Developer
Summary: Universal Immunization Program (UIP) in India is one of the largest public health programs in the world. It targets vaccinating ~30.4